{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:28:03Z","timestamp":1788456483179,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.amjms.2023.08.002","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T20:58:19Z","timestamp":1691528299000},"page":"347-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Healthcare and economic burden of heart failure with amyloidosis: An insight from National Readmission Database"],"prefix":"10.1016","volume":"366","author":[{"given":"Shahzad","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muddasir","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Salehin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Mustajab","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleema","family":"Sadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wissam","family":"Khalife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled F","family":"Chatila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.amjms.2023.08.002_bib0001","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11936-018-0631-1","article-title":"Advances in treatment of cardiac amyloid","volume":"20","author":"Dahm","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.amjms.2023.08.002_bib0002","unstructured":"Healthcare Cost and Utilization Project National Readmission Database. https:\/\/www.hcup-us.ahrq.gov\/nrdoverview.jsp."},{"key":"10.1016\/j.amjms.2023.08.002_bib0003","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443200","article-title":"Immunoglobulin light-chain amyloidosis: from basics to new developments in diagnosis, prognosis, and therapy","volume":"135","author":"Muchtar","year":"2016","journal-title":"Acta Haematol"},{"key":"10.1016\/j.amjms.2023.08.002_bib0004","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","article-title":"Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis","volume":"135","author":"Maurer","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.amjms.2023.08.002_bib0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjms.2023.08.002_bib0006","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjms.2023.08.002_bib0007","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003352","article-title":"Afro-Caribbean heart failure in the United Kingdom: cause, outcomes, and ATTR V122I cardiac amyloidosis","volume":"9","author":"Dungu","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjms.2023.08.002_bib0008","doi-asserted-by":"crossref","first-page":"12","DOI":"10.18087\/cardio.2390","article-title":"[Transthyretin amyloidosis in a cohort of old and very old patients with chronic heart failure]","volume":"S2","author":"Poliakova","year":"2018","journal-title":"Kardiologiia"},{"key":"10.1016\/j.amjms.2023.08.002_bib0009","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005407","article-title":"Epidemiology of cardiac amyloidosis-associated heart failure hospitalizations among fee-for-service Medicare beneficiaries in the United States","volume":"12","author":"Gilstrap","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjms.2023.08.002_bib0010","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.amjcard.2019.08.045","article-title":"Increasing rate of hospital admissions in patients with amyloidosis (from the National Inpatient Sample)","volume":"124","author":"Sperry","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjms.2023.08.002_bib0011","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/13506129.2019.1618261","article-title":"Trends and causes of hospitalizations in patients with amyloidosis","volume":"26","author":"Patil","year":"2019","journal-title":"Amyloid"},{"issue":"3","key":"10.1016\/j.amjms.2023.08.002_bib0012","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.amjms.2023.08.002_bib0013","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2023.08.002_bib0014","series-title":"HCUP Statistical Brief #196","article-title":"Trends in hospital readmissions for four high volume conditions, 2009\u20132013","author":"Fingar","year":"2015"},{"key":"10.1016\/j.amjms.2023.08.002_bib0015","series-title":"HCUP Statistical Brief #172","article-title":"Conditions with the largest number of adult hospital readmissions by payer, 2011","author":"Hines","year":"2014"},{"key":"10.1016\/j.amjms.2023.08.002_bib0016","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/CIRCULATIONAHA.114.010270","article-title":"Hospital readmissions reduction program","volume":"131","author":"Mcllvennan","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2023.08.002_bib0017","unstructured":"Weiss AJ, Jiang HJ. Overview of clinical conditions with frequent and costly hospital readmissions by payer, 2018.https:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb278-Conditions-Frequent-Readmissions-By-Payer-2018.jsp"},{"key":"10.1016\/j.amjms.2023.08.002_bib0018","series-title":"Reducing Hospital Readmissions","author":"Minott","year":"2008"},{"key":"10.1016\/j.amjms.2023.08.002_bib0019","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/jamasurg.2017.4585","article-title":"Association of the Hospital Readmissions Reduction Program with surgical readmissions","volume":"153","author":"Borza","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.amjms.2023.08.002_bib0020","first-page":"29","article-title":"The effect of diabetes case management and Diabetes Resource Nurse program on readmissions of patients with diabetes mellitus","volume":"8","author":"Drincic","year":"2017","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.amjms.2023.08.002_bib0021","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7326\/0003-4819-150-3-200902030-00007","article-title":"Re-engineered hospital discharge program to decrease rehospitalization: a randomized trial","volume":"150","author":"Jack","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjms.2023.08.002_bib0022","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","article-title":"Re-hospitalizations among patients in the Medicare fee-for-service program","volume":"360","author":"Jencks","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2023.08.002_bib0023","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomized controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.amjms.2023.08.002_bib0024","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/pop.2012.0084","article-title":"The influence of postdischage intervention on reducing hospital readmissions in a medicare population","volume":"16","author":"Costantino","year":"2013","journal-title":"Popul Health Manage"},{"issue":"11","key":"10.1016\/j.amjms.2023.08.002_bib0025","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2023.08.002_bib0026","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/CIRCULATIONAHA.118.035831","article-title":"Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis","volume":"139","author":"Solomon","year":"2019","journal-title":"Circulation"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962923012946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962923012946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:43:07Z","timestamp":1757702587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962923012946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0002962923012946"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2023.08.002","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Healthcare and economic burden of heart failure with amyloidosis: An insight from National Readmission Database","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2023.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}